Ranjini K. Sundaram

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity”.

Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity

Translational Oncology(2021)10.1016/j.tranon.2021.101147

N/A

1.8DataRank · unranked

59 citations

Jillian Eckroate, Ranjini K. Sundaram, Ryan B. Jensen, Ranjit S. Bindra, Jennifer Garbarino

Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma

Scientific Reports(2022)10.1038/s41598-022-09614-x

N/A

0.838DataRank · unranked

25 citations

Amrita Sule, Ranjini K. Sundaram, Ranjit S. Bindra, Sachita Ganesa

NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion

Molecular Cancer Research(2024)10.1158/1541-7786.mcr-23-1003

N/A

0.282DataRank · unranked

5 citations

Karlie N. Lucas, Sateja Paradkar, Joseph Edmonds, Sam Friedman, Matthew A. Murray +12 more

Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore

Oncotarget(2021)10.18632/oncotarget.27933

N/A

0DataRank · unranked

3 citations

James Herrington, Adam Hendricson, Piyasena Hewawasam, Mark P. Plummer, Denton Hoyer +4 more

Correction to ‘Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity’

NAR Cancer(2021)10.1093/narcan/zcab047

N/A

0DataRank · unranked

1 citations

Robert J. Aiello, Nalin Leelatian, Jason M. Beckta, Jane Bechtold, Patricia Bourassa +19 more

TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-1000

N/A

0DataRank · unranked

55 citations

Yasuhisa Murai, Keli Agama, Yilun Sun, Liton Kumar Saha, Xi Yang +11 more

Mechanism of Action of KL-50, a Novel Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers

ChemRxiv(2023)10.26434/chemrxiv-2023-zwj94

N/A

0DataRank · unranked

1 citations

Anna Lo, Olga Fedorova, James L. Elia, Susan Gueble, Kingson Lin +15 more

Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers

Journal of the American Chemical Society(2024)10.1021/jacs.3c06483

N/A

0DataRank · unranked

7 citations

Anna Lo, Olga Fedorova, James L. Elia, Susan E. Gueble, Kingson Lin +13 more

Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0012

N/A

0DataRank · unranked

7 citations

Katelyn J. Noronha, Yazhe Wang, Anna P. Friedman, Sateja Paradkar, Hee‐Won Suh +5 more

PARG inhibition induces nuclear aggregation of PARylated PARP1

Structure(2024)10.1016/j.str.2024.09.006

N/A

0DataRank · unranked

4 citations

Julia Purcell, Annie Cui, Samuel R. Friedman, Katelyn J. Noronha, Matthew A. Murray +4 more

Targeted CRISPR knockout screening identifies known and novel chemogenomic interactions between DNA damaging agents and DNA repair genes

NAR Cancer(2025)10.1093/narcan/zcaf052

N/A

0DataRank · unranked

2 citations

James L. Elia, Vijay Menon, Spenser S. Johnson, Sofia R. Arbelaez, Sam Friedman +6 more

Development of Syngeneic Murine Glioma Models with Somatic Mismatch Repair Deficiency to Study Therapeutic Responses to Alkylating Agents and Immunotherapy

Current Protocols(2025)10.1002/cpz1.70097

N/A

0DataRank · unranked

1 citations

Ranjini K. Sundaram, Karla Alejandra Lopez, Teresa Lee, Susan Gueble, Juan C. Vasquez +1 more

DNA damage response profile distinguishes poor-acting gliomas with shared methylome signatures

Neuro-Oncology(2025)10.1093/neuonc/noaf199

N/A

0DataRank · unranked

0 citations

Charu Singh, Richard Bouffard, Ranjini K. Sundaram, Kirsten E. Diggins, William Sullivan +7 more

Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors

NAR Cancer(2021)10.1093/narcan/zcab018

N/A

0DataRank · unranked

33 citations

Jinny Van Doorn, Ranjini K. Sundaram, Sachita Ganesa, Juan C. Vasquez, Ranjit S. Bindra +1 more

Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity

NAR Cancer(2021)10.1093/narcan/zcab021

N/A

0DataRank · unranked

30 citations

Robert J. Aiello, Nalin Leelatian, Jason M. Beckta, Jane Bechtold, Patricia Bourassa +19 more